rhMNV-BMP-2 (AMMS)

重组人MNV-骨形态发生蛋白-2(军事医学科学院)

Report date: 2024/10/24 13:21:23

Base Information

Drug NamerhMNV-BMP-2 (AMMS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionCell differentiation stimulantsBone morphogenetic proteins replacementsBone morphogenetic protein receptor type-2 agonists
TargetsBone morphogenetic proteinsBone morphogenetic protein receptor type-2
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A